What's new? Log in Free sign up

Electromed (ELMD)

Company Profile

Company profile

Ticker

ELMD

Exchange

Website

CEO

Mr. James L. Cunniff

Incorporated

Location

Fiscal year end

Sector

Health Care and Social Assistance > Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

MidCap Financial Investment • Varian Medical Systems • CONMED • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Man Ahl Diversified I ...

Former names

Protagonist Inc, Protagonist Therapeutics Inc

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

411732920

ELMD stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

B. Riley Securities

Latest filings (excl ownership)

View all

Quarterly report

11 Feb 25

Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter

Amendments to Articles of Incorporation or Bylaws

Quarterly report

12 Nov 24

Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results

Additional proxy soliciting materials

Definitive proxy

1 Oct 24

Annual report to shareholders

Electromed, Inc. Announces Share Repurchase Authorization

27 Aug 24

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Notice of proposed sale of securities

Notice of proposed sale of securities

KATHLEEN SKARVAN

Notice of proposed sale of securities (amended)

Notice of proposed sale of securities

James L. Cunniff

Financial summary

Financial statements Chart ELMD financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 24	Jun 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Electromed earnings reports.

Institutional ownership, Q4 2024

ELMD institutional ownership history Ownership history

55.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	88	58	+51.7%
Opened positions	33	15	+120.0%
Closed positions	3	3	–
Increased positions	24	15	+60.0%
Reduced positions	18	13	+38.5%

13F shares	Current	Prev Q	Change
Total value	82.00 bn	45.83 bn	+78.9%
Total shares	4.66 mm	3.94 mm	+18.3%
Total puts	9.70 k	3.70 k	+162.2%
Total calls	27.10 k	4.20 k	+545.2%
Total put/call ratio	0.4	0.9	-59.4%

Largest owners	Shares	Value	Change
Summers Value Fund	521.69 k	$0.00	0.0%
George H. Winn	430.30 k	$9.76 mm	0.0%
Zenith Sterling Advisers	395.57 k	$4.19 mm	0.0%
Vanguard	362.39 k	$10.71 bn	-1.3%
Punch & Associates Investment Management	270.80 k	$8.00 bn	-24.8%
Dimensional Fund Advisors	250.22 k	$7.39 bn	-10.1%
Acadian Asset Management	214.10 k	$6.33 mm	0.0%
Gamco Investors	134.00 k	$3.96 bn	-0.7%
Renaissance Technologies	118.33 k	$3.50 bn	-4.1%
Arrowstreet Capital, Limited Partnership	114.58 k	$3.39 bn	+261.0%

Largest transactions	Shares	Bought/sold	Change
Punch & Associates Investment Management	270.80 k	-89.45 k	-24.8%
Arrowstreet Capital, Limited Partnership	114.58 k	+82.84 k	+261.0%
RJF Raymond James Financial	59.55 k	+59.55 k	NEW
Sowell Financial Services	51.39 k	+51.39 k	NEW
Lazard Asset Management	47.91 k	+47.67 k	+19860.8%
Qube Research & Technologies	64.27 k	+47.49 k	+283.1%
Two Sigma Investments	42.48 k	+42.48 k	NEW
RY Royal Bank of Canada	0.00	-39.38 k	EXIT
Navellier & Associates	56.37 k	+39.21 k	+228.5%
Susquehanna International	56.73 k	+31.15 k	+121.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ELMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	27.297	50,751	1.39 mm	65,714
21 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.99	735	21.31 k	116,465
21 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.16	11,990	337.64 k	117,200
21 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.99	734	21.28 k	270,267
21 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.16	11,992	337.69 k	271,001
20 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	29.806	1,948	58.06 k	129,190
20 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.71	15,689	450.43 k	131,138
20 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	29.806	1,947	58.03 k	282,993
20 Feb 25	Andrew Summers	Common Stock	Sell	Dispose S	Yes	No	28.71	15,689	450.43 k	284,940
18 Feb 25	Skarvan Kathleen	Common Stock	Sell	Dispose S	No	No	29.28	38,954	1.14 mm	32,622

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

B. Riley Securities Initiates Coverage On Electromed with Buy Rating, Announces Price Target of $38

B. Riley Securities analyst Kyle Bauser initiates coverage on Electromed (NYSE:ELMD) with a Buy rating and announces Price Target of $38.

Electromed Q2 2025 GAAP EPS $0.22 Beats $0.19 Estimate, Sales $16.255 Miss $15.300M Estimate

Electromed (AMEX:ELMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.19 by 15.79 percent. This is a 15.79 percent increase over earnings of $0.19 per share from the same

Earnings Scheduled For February 11, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session

Press releases

From Benzinga Pro

Electromed Inc. to Participate in Upcoming Investor Conferences

Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the following upcoming investor conferences: The

Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter

Company maintained strong momentum to deliver another quarter of record revenue and earnings, while continuing to invest in multiple strategic growth initiatives Electromed, Inc. ("Electromed" or the "Company")

Electromed, Inc. Schedules its Second Quarter Fiscal 2025 Financial Results Conference Call for February 11, 2025 at 5:00 p.m. ET

Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 second quarter ended December 31, 2024,

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.